Diabetic Macular Edema Treatment | Retina Center Tijuana скачать в хорошем качестве

Diabetic Macular Edema Treatment | Retina Center Tijuana

Diabetic macular edema (DME) is the most frequent cause of vision loss in patients with diabetes and is an important public health problem. An estimated 425 million people are affected by diabetes worldwide in 2017 (IDF Atlas Eighth Edition 2017), and the number of people with diabetes is expected to double from 2005 to 2030. The pathogenesis of diabetic macular edema is multifactorial, and several therapeutic modalities have been proposed for the treatment of diabetic macular edema. Recent clinical trials show the improved visual acuity and macular swelling, and currently antivascular endothelial growth factor (VEGF) therapy has become the first line of treatment of diabetic macular edema. Sometimes, these eyes with diabetic macular edema may be refractory to anti-VEGF, fortunately the advancing technology and new forms of therapies using corticosteroids, laser, and vitrectomy can be alternative tools for the persistent or refractory anti-VEGF drugs. http://www.aurelianomoreno.com/acerca...